VOLITIONRX LTD
Financial highlights
| Metric | FY December 31, 2025 | FY December 31, 2024 | FY December 31, 2023 | FY December 31, 2022 | FY December 31, 2021 |
|---|---|---|---|---|---|
| Revenue | $1.7M | $1.2M | $775,302 | $306,392 | $90,035 |
| Operating income | -$21.7M | -$27.0M | -$36.0M | -$31.8M | -$28.3M |
| Operating expenses | $23.5M | $28.3M | $36.8M | $32.1M | $28.4M |
| Cash from operations | -$19.7M | -$25.9M | -$18.1M | -$15.3M | -$20.9M |
| Capital expenditure | $89,558 | $277,499 | $1.1M | $1.6M | $973,559 |
| Free cash flow | -$19.8M | -$26.2M | -$19.1M | -$16.8M | -$21.8M |
| Share repurchases | — | $0 | $31,772 | $0 | — |
| Impairments | — | $0 | $0 | $0 | $0 |
| Total assets | $6.9M | $9.4M | $28.0M | $18.3M | $27.5M |
| Total liabilities | $42.5M | $35.5M | $36.7M | $21.4M | $9.8M |
Shares outstanding 8.3M · Free float 92.8%
Annual filing data through FY ended December 31, 2025; float as of July 8, 2026.